Home / Recalls / Medical Devices
Stryker Howmedica Osteonics Corp. recalls Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fi
Recalled September 21, 2016 · FDA recall Z-2791-2016 · Stryker Howmedica Osteonics
Hazard
Stryker discovered that a Tibial Nail and femoral Nail were incorrectly labeled and distributed to the field. · FDA Class II
Units
1 unit in total
Sold at
US distribution to state of: CA.
Description
Stryker discovered that a Tibial Nail and femoral Nail were incorrectly labeled and distributed to the field.
Product
Supracondylar Nail T2 SCN 09x300 mm T2 Supracondylar Nail System is intended to provide strong and stable internal fixation with minimal soft tissue irritation of the distal femur. (1( Open and closed femoral fractures, (2) Pseudoarthrosis and correction osteotomy, (3) Pathologic fractures, impending pathologic fractures, and tumor resections, (4) Supracondylar fractures, including those with intra-articular extension, (5) Fractures distal to a Total Hip Prosthesis and (6) Non-unions and malunions
Manufacturer(s)
Stryker Howmedica Osteonics Corp.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →